Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

469 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PPARβ/δ activation of CD300a controls intestinal immunity.
Tanaka T, Tahara-Hanaoka S, Nabekura T, Ikeda K, Jiang S, Tsutsumi S, Inagaki T, Magoori K, Higurashi T, Takahashi H, Tachibana K, Tsurutani Y, Raza S, Anai M, Minami T, Wada Y, Yokote K, Doi T, Hamakubo T, Auwerx J, Gonzalez FJ, Nakajima A, Aburatani H, Naito M, Shibuya A, Kodama T, Sakai J. Tanaka T, et al. Among authors: yokote k. Sci Rep. 2014 Jun 24;4:5412. doi: 10.1038/srep05412. Sci Rep. 2014. PMID: 24958459 Free PMC article.
Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study).
Yokote K, Bujo H, Hanaoka H, Shinomiya M, Mikami K, Miyashita Y, Nishikawa T, Kodama T, Tada N, Saito Y. Yokote K, et al. Atherosclerosis. 2008 Dec;201(2):345-52. doi: 10.1016/j.atherosclerosis.2008.02.008. Epub 2008 Feb 16. Atherosclerosis. 2008. PMID: 18472103 Clinical Trial.
Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
Sato S, Kawamura H, Takemoto M, Maezawa Y, Fujimoto M, Shimoyama T, Koshizaka M, Tsurutani Y, Watanabe A, Ueda S, Halevi K, Saito Y, Yokote K. Sato S, et al. Among authors: yokote k. Biochem Biophys Res Commun. 2009 Feb 6;379(2):411-6. doi: 10.1016/j.bbrc.2008.12.088. Epub 2008 Dec 27. Biochem Biophys Res Commun. 2009. PMID: 19114027
CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.
Shimoyama T, Hiraoka S, Takemoto M, Koshizaka M, Tokuyama H, Tokuyama T, Watanabe A, Fujimoto M, Kawamura H, Sato S, Tsurutani Y, Saito Y, Perbal B, Koseki H, Yokote K. Shimoyama T, et al. Among authors: yokote k. Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):675-82. doi: 10.1161/ATVBAHA.110.203356. Epub 2010 Feb 5. Arterioscler Thromb Vasc Biol. 2010. PMID: 20139355
Primary lung cancer associated with Werner syndrome.
Ohnishi S, Fujimoto M, Oide T, Nakatani Y, Tsurutani Y, Koshizaka M, Mezawa M, Ishikawa T, Takemoto M, Yokote K. Ohnishi S, et al. Among authors: yokote k. Geriatr Gerontol Int. 2010 Oct;10(4):319-23. doi: 10.1111/j.1447-0594.2010.00638.x. Geriatr Gerontol Int. 2010. PMID: 20887625
An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic mice.
Koshizaka M, Takemoto M, Sato S, Tokuyama H, Fujimoto M, Okabe E, Ishibashi R, Ishikawa T, Tsurutani Y, Onishi S, Mezawa M, He P, Honjo S, Ueda S, Saito Y, Yokote K. Koshizaka M, et al. Among authors: yokote k. Exp Diabetes Res. 2012;2012:159874. doi: 10.1155/2012/159874. Epub 2012 Jan 29. Exp Diabetes Res. 2012. PMID: 22319521 Free PMC article.
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders.
Muto T, Sashida G, Oshima M, Wendt GR, Mochizuki-Kashio M, Nagata Y, Sanada M, Miyagi S, Saraya A, Kamio A, Nagae G, Nakaseko C, Yokote K, Shimoda K, Koseki H, Suzuki Y, Sugano S, Aburatani H, Ogawa S, Iwama A. Muto T, et al. Among authors: yokote k. J Exp Med. 2013 Nov 18;210(12):2627-39. doi: 10.1084/jem.20131144. Epub 2013 Nov 11. J Exp Med. 2013. PMID: 24218139 Free PMC article.
469 results